14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients

Table 2

Differential CpGs identified by robust likelihood-based survival analysis.

Gene ID	nloglik	AIC
cg17173423	433.13	868.26
cg20073553	431.63	867.26
cg12188860	431.46	868.92
cg21578906	429.97	867.94
cg06226384	421.27	852.53
cg04711324	416.91	845.82
cg08668790	416.01	846.03
cg00504595	413.38	842.76
cg22477971	411.09	840.17
cg18536148	410.47	840.94
cg14988503	410.17	842.34
cg24898863	408.49	840.98
cg11500797	408.09	842.19
cg05767404	407.33	842.65
cg00891278	407.13	844.26
cg19345602	404.52	841.04
cg26059632	403.2	840.39
cg05488632	402.41	840.82
cg15747595	401.03	840.07
cg04574507	399.42	838.84
cg04731384	399.12	840.23
cg06437004	399.11	842.23
cg15842276	398.82	843.63
cg22815110	398.21	844.43
cg23163573	397.5	844.99
cg14141399	397.5	846.99
cg08460435	396.33	846.66
cg16673198	392.47	840.93
cg18343292	389.42	836.83
cg19279346	389.18	838.35
cg24432073	385.75	833.49
cg07014174	384.54	833.09
cg14659547	383.51	833.01